Liver Cancer

Liver Disease

LIver Cancer

Chronic inflammation and scarring can also result in malignancy in the liver

 

Chronic inflammation and scarring in the liver, due to NASH that leads to cirrhosis, can also result in a type of liver cancer called hepatocellular carcinoma (HCC).  HCC, a malignant hepatoma, is the most common form of liver cancer and is considered a primary form of liver cancer (i.e. forms in the liver).

According to The American Cancer Society, about 40,000 Americans are diagnosed with primary liver cancer per year and is one of the fastest growing cancers in the US. Primary liver cancer is about twice as common in men than in women.

HCC has a very high fatality rate and requires surgical intervention, transplantation and/or chemotherapy.

liver-cancerpicture.png

The progression of liver disease

Understanding the progression of liver disease may help you make better health choices.

NAFLD | NASH

NAFLD | NASH

NAFLD is the most prevalent liver disease in developed countries. It is characterized by fat build up in the liver, typically does not cause noticeable symptoms, and marks the beginning of liver disease. Prolonged fat accumulation leads to chronic inflammation and the development of NASH.

[LEARN MORE]

Fibrosis

Fibrosis

When NASH and chronic inflammation go untreated it will start to cause the liver to scar. These scar tissues will replace the healthy liver tissue and reduce liver function. May see symptoms such as abdominal pain and swelling.

[LEARN MORE]

Cirrhosis

Cirrhosis

High accumulation of scar tissue leads to Cirrhosis of the liver which noticeably reduces liver function, and if left untreated, can lead to liver failure. Key symptoms include jaundice, gastrointestinal bleeding and significant abdominal swelling.

[LEARN MORE]

Liver Cancer

Liver Cancer

Chronic inflammation and Cirrhosis (scarring) can lead to malignancy within the liver, or liver cancer. The most common type of primary liver cancer is hepatocellular carcinoma, which displays similar symptoms to cirrhosis and can also lead to liver failure.

[LEARN MORE]

About FIBRONOSTICS

We are a team of life science experts, physicians, mathematicians, health IT professionals and software architects.